LCI-GU-URO-CRI-001: Crizotinib in Patients With c-MET or RON-Positive Metastatic Urothelial Cancer
Condition(s):Urinary Bladder Neoplasms; Ureteral Neoplasms; Urethral NeoplasmsLast Updated:November 3, 2022Terminated
Hide Studies Not Open or Pending
Condition(s):Urinary Bladder Neoplasms; Ureteral Neoplasms; Urethral NeoplasmsLast Updated:November 3, 2022Terminated
Condition(s):Urethral Neoplasms; Neoplasms, Urethral; Cancer of the Urethra; Urethral CancerLast Updated:March 13, 2024Completed
Condition(s):Urothelial Carcinoma; Urethral Neoplasms; Urinary Bladder Neoplasms; Kidney NeoplasmsLast Updated:October 18, 2022Completed
Condition(s):Bladder Neoplasms; Ureteral Neoplasms; Urethral Neoplasms; Carcinoma, Transitional CellLast Updated:June 4, 2009Completed
Condition(s):Solid Tumor; Urethral CancerLast Updated:September 28, 2023Active, not recruiting
Condition(s):Bladder Cancer; Urethral CancerLast Updated:June 15, 2023Completed
Condition(s):Urothelial Carcinoma; Bladder Cancer; Urethral Cancer; Cancer of the UreterLast Updated:September 29, 2023Completed
Condition(s):Bladder Cancer; Urethral CancerLast Updated:July 3, 2013Completed
Condition(s):Bladder Cancer; Urethral CancerLast Updated:May 14, 2015Completed
Condition(s):Bladder Cancer; Urethral CancerLast Updated:January 31, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.